Spots Global Cancer Trial Database for A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Official Title: A Phase I Clinical Trial of IMMH-010 in Patients With Advanced Malignant Solid Tumors
Study ID: NCT04343859
Conditions
Interventions
Study Description
Brief Summary: Phase I study of IMMH-010 in patients with advanced malignant solid tumors
Detailed Description: To evaluate the safety and tolerability of single-dose and multi-dose IMMH-010 in patients with advanced solid tumors, et al.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Guangdong Provincial People's Hospital, Guangzhou, , China
Contact Details
Name: Yilong Wu
Affiliation: Guangdong Provincial People's Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
